Allard R.J.V. Vossen

Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis

Jóhann E. Guðjónsson, Lam C. Tsoi, Feiyang Ma et al. · JCI Insight · 2020 · 177 citations · Full text

Tyrosine Kinase, Immune Regulation, Immunology +27

Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial

Allard R.J.V. Vossen, Martijn B. A. van Doorn, Hessel H. van der Zee et al. · Journal of the American Academy of Dermatology · 2018 · 127 citations

Moderate Hidradenitis Suppurativa, Allergy, Clinical Dermatology +3

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study

Allard R.J.V. Vossen, Annelien Schoenmakers, Kelsey R. van Straalen et al. · American Journal of Clinical Dermatology · 2017 · 62 citations · Full text

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (<scp>IL</scp>)‐17A,<scp>IL</scp>‐12/23 and<scp>CD</scp>20 in hidradenitis suppurativa: an<i>ex vivo</i>study

Allard R.J.V. Vossen, Christine B. Ardon, Hessel H. van der Zee et al. · British Journal of Dermatology · 2019 · 49 citations · Full text

Correlation of the refined Hurley classification for hidradenitis suppurativa with patient‐reported quality of life and objective disease severity assessment

Angelique Rondags, Kelsey R. van Straalen, J.R. Hasselt et al. · British Journal of Dermatology · 2018 · 34 citations · Full text